March 18, 2011 - GMP Notice of Sedar Re-Filing

Toronto, ON. (March 18, 2011) – GMP Capital Inc. (“GMP”) (TSX: GMP and GMP.PR.B) announced that it has re-filed its audited financial statements and accompanying management’s discussion and analysis for the year ended December 31, 2010 to correct a calculation error relating to earnings per common share for 2009.


March 9, 2011 - GMP Declares Series B Preferred Share Dividend

Toronto, ON. (March 9, 2011) – GMP Capital Inc. (“GMP”) (TSX: GMP and GMP.PR.B) announced today that its board of directors has declared a quarterly cash dividend of $0.1394 per Cumulative 5-Year Rate Reset Preferred Shares, Series B payable on March 31, 2011 to shareholders of record at the close of business on March 18, 2011.


March 2, 2011 - GMP Announces Q4/10 and 2010 Results

For further information about GMP Capital Inc., our results for fiscal 2010 and the meaning of certain references, this press release should be read in conjunction with our 2010 Annual Financial Statements and accompanying Management’s Discussion and Analysis for the year ended December 31, 2010, and our 2010 Annual Information Form, which can be accessed on our website at and on SEDAR at

 Toronto, ON. (March 2, 2011) – GMP Capital Inc. (“GMP”) (TSX: GMP) today reported revenue of $148.4 million in fourth quarter 2010, representing a 39% increase compared with the same period a year ago due to stronger revenue performance across all business segments, led by record quarterly revenues in the Capital Markets segment. Net income was $38.0 million ($0.54 per basic share) compared with net income of $19.5 million in fourth quarter 2009 ($0.28 per basic share), generating a return on shareholders’ equity (“ROE”)1 of 48.0% in fourth quarter 2010. On March 1, 2011, the Board of Directors approved a 33% increase in the quarterly cash dividend from $0.06 to $0.08 per common share, representing payment for the fourth quarter ended December 31, 2010.


March 1, 2011 - GMP Announces Closing of Over-Allotment Option

Toronto, ON. (March 1, 2011) – GMP Capital Inc. (“GMP”) (TSX: GMP) announced today that it has closed the over-allotment option granted to the underwriters in connection with GMP’s bought deal public offering of Cumulative 5-Year Rate Reset Preferred Shares, Series B (the “Series B Shares”), which closed on February 22, 2011. As a result of the exercise of the over-allotment option, GMP sold an additional 600,000 Series B Shares at a price of $25.00 per share for additional gross proceeds of $15,000,000. In total, GMP has issued 4,600,000 Series B Shares for aggregate gross proceeds of $115,000,000. The Series B Shares trade on the Toronto Stock Exchange under the trading symbol “GMP.PR.B”.



To receive news and events at RF Capital Group., please email